A share price of ANI Pharmaceuticals Inc [ANIP] is currently trading at $62.72, down -0.84%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ANIP shares have gain 2.23% over the last week, with a monthly amount drifted -2.58%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
ANI Pharmaceuticals Inc [NASDAQ: ANIP] stock has seen the most recent analyst activity on March 15, 2024, when CapitalOne initiated its Overweight rating and assigned the stock a price target of $80. Previously, H.C. Wainwright reaffirmed its Buy rating on August 22, 2023, and elevated its price target to $73. On March 01, 2023, Guggenheim initiated with a Buy rating and assigned a price target of $55 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $50 on September 07, 2022. Truist initiated its recommendation with a Buy and recommended $70 as its price target on November 02, 2021. Cantor Fitzgerald downgraded its rating to Neutral for this stock on May 07, 2020. In a note dated September 12, 2019, Guggenheim initiated an Buy rating.
ANI Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $48.20 and $70.81. Currently, Wall Street analysts expect the stock to reach $71 within the next 12 months. ANI Pharmaceuticals Inc [NASDAQ: ANIP] shares were valued at $62.72 at the most recent close of the market. An investor can expect a potential return of 13.2% based on the average ANIP price forecast.
Analyzing the ANIP fundamentals
Trailing Twelve Months sales for ANI Pharmaceuticals Inc [NASDAQ:ANIP] were 538.95M which represents 18.44% growth. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.06 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 61.82 points at the first support level, and at 60.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 63.70, and for the 2nd resistance point, it is at 64.68.
Ratios To Look Out For
To put it in perspective, the Current Ratio for ANI Pharmaceuticals Inc [NASDAQ:ANIP] is 3.97. As well, the Quick Ratio is 3.07, while the Cash Ratio is 1.72. Considering the valuation of this stock, the price to sales ratio is 2.45, the price to book ratio is 2.90 and price to earnings (TTM) ratio is 51.28.
Transactions by insiders
Recent insider trading involved Cook Meredith, SR. VP, GENERAL COUNSEL & SEC., that happened on Aug 13 ’24 when 250.0 shares were sold. HEAD OF R&D, COO-NOVITIUM OPS, Shanmugam Muthusamy completed a deal on Jul 18 ’24 to sell 2743.0 shares. Meanwhile, HEAD OF R&D, COO-NOVITIUM OPS Shanmugam Muthusamy sold 22000.0 shares on Jul 16 ’24.
